Cite
HARVARD Citation
Lübbert, M. et al. (2017). Elevated fetal haemoglobin is a predictor of better outcome in MDS/AML patients receiving 5‐aza‐2′‐deoxycytidine (Decitabine). British journal of haematology. pp. 609-617. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lübbert, M. et al. (2017). Elevated fetal haemoglobin is a predictor of better outcome in MDS/AML patients receiving 5‐aza‐2′‐deoxycytidine (Decitabine). British journal of haematology. pp. 609-617. [Online].